Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 1Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Myoma 2Menorrhagia 2Leiomyoma 2Myofibroma 1

Interventions

Uterine Myomectomy 11Hysterectomy 3Vitamin D 2Vitamin B 6 2Uterine Artery Embolization 2Tranexamic Acid 2Saline Solution 2Embolization, Therapeutic 2Bupivacaine 2Anesthesia, Obstetrical 2Anesthesia, General 2gadoterate meglumine 1epigallocatechin gallate 1Videotape Recording 1Vasopressins 1Vascular Access Devices 1Tourniquets 1Thoracic Surgery, Video-Assisted 1Sodium Chloride 1Salpingectomy 1Robotic Surgical Procedures 1Radiofrequency Ablation 1Oxytocin 1Microspheres 1Leuprolide 1Hysteroscopy 1Holistic Health 1Gonadotropins 1Gonadotropin-Releasing Hormone 1Endoscopic Mucosal Resection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Leiomyoma × Uterine Artery Embolization × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡